4-(Methoxycarbonyl)-2-methylbenzoic acid - CAS 1245919-29-2
Catalog: |
BB059354 |
Product Name: |
4-(Methoxycarbonyl)-2-methylbenzoic acid |
CAS: |
1245919-29-2 |
Synonyms: |
4-(METHOXYCARBONYL)-2-METHYLBENZOIC ACID; 4-methoxycarbonyl-2-methylbenzoic acid |
IUPAC Name: | 4-methoxycarbonyl-2-methylbenzoic acid |
Description: | 4-(Methoxycarbonyl)-2-methylbenzoic acid |
Molecular Weight: | 194.18 |
Molecular Formula: | C10H10O4 |
Canonical SMILES: | CC1=C(C=CC(=C1)C(=O)OC)C(=O)O |
InChI: | InChI=1S/C10H10O4/c1-6-5-7(10(13)14-2)3-4-8(6)9(11)12/h3-5H,1-2H3,(H,11,12) |
InChI Key: | ZQKSVHOYMATPAD-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113621175-A | Efficient isotactic polypropylene beta-crystal form nucleating agent and preparation method and application thereof | 20210813 |
WO-2021126999-A1 | Use of biomarkers in identifying patients that will be responsive to treatment with a prmt5 inhibitor | 20191217 |
WO-2020156241-A1 | Aromatic ring or heteroaromatic ring compounds, preparation method therefor and medical use thereof | 20190131 |
AU-2020214889-A1 | Aromatic ring or heteroaromatic ring compounds, preparation method therefor and medical use thereof | 20190131 |
CA-3128416-A1 | Aromatic ring or heteroaromatic ring compounds, preparation method therefor and medical use thereof | 20190131 |
CN-112955448-A | Aromatic ring or aromatic heterocyclic compound and preparation method and medical application thereof | 20190131 |
TW-202115052-A | Aromatic ring or aromatic heterocyclic compounds, preparation method and medical use thereof | 20190131 |
EP-3919489-A1 | Aromatic ring or heteroaromatic ring compounds, preparation method therefor and medical use thereof | 20190131 |
JP-2022518603-A | Aromatic ring or aromatic heterocyclic compound, its production method and pharmaceutical use | 20190131 |
KR-20210123337-A | Aromatic ring or heteroaromatic ring compound, preparation method thereof and medical use thereof | 20190131 |
Complexity: | 236 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 194.0579088 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 194.0579088 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 63.6Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS